Skip to main content
. 2022 Apr 21;27(5):338–e368. doi: 10.1093/oncolo/oyab065
Name *NC/NA 1 2 3 4 5 All Grades
Neutrophil count decreased 0% 10% 24% 62% 5% 0% 100%
White blood cell decreased 57% 5% 10% 19% 10% 0% 43%
Lymphocyte count decreased 76% 0% 14% 5% 5% 0% 24%
Fatigue 10% 38% 38% 14% 0% 0% 90%
Anemia 19% 48% 29% 5% 0% 0% 81%
Left ventricular systolic dysfunction 90% 0% 5% 5% 0% 0% 10%
Pneumonitis 95% 0% 0% 5% 0% 0% 5%
Pleural effusion 90% 0% 5% 5% 0% 0% 10%
Dyspnea 90% 0% 5% 5% 0% 0% 10%
ALT, SGPT (serum glutamic pyruvic transaminase) 71% 24% 0% 5% 0% 0% 29%
AST, SGOT(serum glutamic oxaloacetic transaminase) 57% 19% 10% 14% 0% 0% 43%
Blood bilirubin increased 76% 10% 5% 5% 5% 0% 24%
Hyponatremia 95% 0% 0% 5% 0% 0% 5%
Hypokalemia 90% 5% 0% 5% 0% 0% 10%
Hypercalcemia 95% 0% 0% 5% 0% 0% 5%
Hypoalbuminemia 81% 10% 5% 5% 0% 0% 19%
Hepatobiliary disorders - Other, specify 100% 0% 0% 0% 0% 0% 0%
Hypertension 95% 0% 5% 0% 0% 0% 5%
Blood and lymphatic system 
disorders - Other, specify 95% 0% 0% 5% 0% 0% 5%
Nausea 24% 62% 14% 0% 0% 0% 76%
Vomiting 57% 38% 5% 0% 0% 0% 43%
Peripheral sensory neuropathy 71% 19% 5% 5% 0% 0% 29%
Alopecia 24% 24% 52% 0% 0% 0% 76%
Skin and subcutaneous tissue 
disorders - Other, specify 62% 33% 5% 0% 0% 0% 38%
Diarrhea 71% 19% 10% 0% 0% 0% 29%
Platelet count decreased 67% 19% 14% 0% 0% 0% 33%
Mucositis oral 95% 5% 0% 0% 0% 0% 5%
Lung infection 100% 0% 0% 0% 0% 0% 0%
Activated partial thromboplastin time prolonged 100% 0% 0% 0% 0% 0% 0%
Syncope 100% 0% 0% 0% 0% 0% 0%
Pain in extremity 90% 0% 0% 10% 0% 0% 10%
Chest wall pain 90% 5% 0% 5% 0% 0% 10%
Back pain 90% 0% 5% 5% 0% 0% 10%
Buttock pain 95% 0% 0% 5% 0% 0% 5%
Neck pain 95% 0% 0% 5% 0% 0% 5%
Voice changes/dysarthria (eg, hoarseness, loss or alteration invoice, laryngitis) 95% 0% 0% 5% 0% 0% 5%